reuters
J&J announces $5bn share repurchase
December 18, 2018Manufacturing and Production J&J, JJ, Shares, asbestos, baby powder, reuters, scandal
New Jersey-based pharma firm Johnson & Johnson plans to buy back $5 billion in shares after news agency Reuters released …
J&J shares plummet after asbestos cover up allegations emerge
December 17, 2018Sales and Marketing J&J, JJ, Johnson & Johnson, asbestos, reuters
Shares in American healthcare firm Johnson & Johnson plummeted on Friday after news agency Reuters reported that the New Jersey-based …
Whistleblower accuses Novartis of paying bribes in Turkey to push sales
April 1, 2016Business Services, Medical Communications, Sales and Marketing Financial, Novartis, legal, reuters
An anonymous whistleblower has accused Swiss drugmaker Novartis (SIX: NOVN) of paying bribes in Turkey through a consulting firm to …
Regulators ‘more efficient at approving drugs’
January 19, 2015Research and Development, Sales and Marketing EMA, EMA), FDA, Health Canada, PMDA)., Pharmaceutical and Medical Devices Agency, Swissmedic, TGA, approvals, cirs, reuters
Global regulatory bodies have become faster at approving new drug products more quickly and consistently, according to a new analysis …
Reuters chief executive joins Pfizer board
July 2, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, james smith, reuters
Pfizer has appointed the chief executive of information and media giant Thomson Reuters to its board of directors. James Smith …
Bayer to make $14 bn move for Merck unit
May 2, 2014Manufacturing and Production, Research and Development, Sales and Marketing Bayer, Boehringer, Merck, Novartis, Reckitt Benckiser, claritin, reuters
Bayer is in talks with Merck & Co to buy its consumer business and is willing to pay $14 billion …
Report: ‘R&D isn’t paying’
December 3, 2013Research and Development, Sales and Marketing Deloitte, R&D, pharma, research and development, reuters
On average, the world’s biggest pharma companies are not getting enough of a return out of their R&D efforts, according …
Latest content
FibroFind appoints Lee Borthwick as CEO
